Skip to content
The Policy VaultThe Policy Vault

Arcalyst (rilonacept subcutaneous injection) — Cigna

Recurrent Pericarditis

Initial criteria

  • Patient is ≥ 12 years of age; AND
  • Patient has recurrent pericarditis

Approval duration

initial 3 months